DOCSLIB.ORG

Bioorganic Chemistry 89 (2019) 103004

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Bioorganic Chemistry 89 (2019) 103004 Bioorganic Chemistry 89 (2019) 103004 Contents lists available at ScienceDirect Bioorganic Chemistry journal homepage: www.elsevier.com/locate/bioorg Synthesis, biological evaluation and in silico studies of novel N-substituted T phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors ⁎ ⁎ Cüneyt Türkeşa, , Mustafa Arslanb, , Yeliz Demirc, Liridon Çoçajd, Arleta Rifati Nixhad, Şükrü Beydemire a Department of Biochemistry, Faculty of Pharmacy, Erzincan Binali Yıldırım University, 24100 Erzincan, Turkey b Department of Chemistry, Faculty of Arts and Sciences, Sakarya University, 54187 Sakarya, Turkey c Department of Pharmacy Services, Nihat Delibalta Göle Vocational High School, Ardahan University, 75700 Ardahan, Turkey d Department of Chemistry, Faculty of Mathematical and Natural Sciences, University of Prishtina, 10000 Prishtina, Republic of Kosova, Serbia e Department of Biochemistry, Faculty of Pharmacy, Anadolu University, 26470 Eskişehir, Turkey ARTICLE INFO ABSTRACT Keywords: The synthesis, characterization and biological evaluation of a series of novel N-substituted phthalazine sulfo- Sulfonamide namide (5a-l) are disclosed. Phthalazines which are nitrogen-containing heterocyclic compounds are biologi- Phthalazine cally preferential scaffolds, endowed with versatile pharmacological activity, such as anti-inflammatory, car- Carbonic anhydrase diotonic vasorelaxant, anticonvulsant, antihypertensive, antibacterial, anti-cancer action. The compounds were Acetylcholinesterase investigated for the inhibition against the cytosolic hCA I, II and AChE. Most screened sulfonamides showed high Enzyme inhibitors potency in inhibiting hCA II, widely involved in glaucoma, epilepsy, edema, and other pathologies (K s in the Molecular docking i ranging from 6.32 ± 0.06 to 128.93 ± 23.11 nM). hCA I was inhibited with Kis in the range of 6.80 ± 0.10–85.91 ± 7.57 nM, whereas AChE in the range of 60.79 ± 3.51–249.55 ± 7.89 nM. ADME pre- diction study of the designed N-substituted phthalazine sulfonamides showed that they are not only with car- bonic anhydrase and acetylcholinesterase inhibitory activities but also with appropriate pharmacokinetic, physicochemical parameters and drug-likeness properties. Also, in silico docking studies were investigated the binding modes of selected compounds, to hCA I, II, and AChE. 1. Introduction employed as therapeutic agents owing to their anti-inflammatory, car- diotonic vasorelaxant, anticonvulsant [4], antihypertensive [5], anti- Nitrogen-containing heterocyclic compounds have been significant bacterial [6], anti-cancer features [7], and carbonic anhydrase enzyme interest because of their common applicability in the past few decades. activity [8]. Several commercially available phthalazine derivative drugs, These compounds have an essential role in biological systems as ther- for instance, hydralazine, azelastine, budralazine, zaleplon, luminal, zo- apeutic agents and found in many of the compounds in medicinal polrestat, and MY5445 are used in the treatment of antihypertensive agent chemistry [1]. The compounds containing heterocyclic groups such as for pulmonary hypertension, allergic rhinitis, vasorelaxation, anti- pyridines, piperazines, indoles, pyrazoles, thiazolidine-4-ones have re- histaminic, insomnia and which are shown in Scheme 1 [9,10]. ceived great importance because of their biological and pharmacolo- Sulfonamides are an essential compound for the synthesis of bac- gical activities [2]. They are widely found in nature, and their utiliza- teriostatic antibiotics. They are known as sulfa drugs and were used tion is increasing more and more with each passing day as functional, against bacterial infections before discovering penicillin [11]. The pharmaceutical, and agrochemicals materials [3]. compounds have a wide range of biological activities; for example, Phthalazine derivatives are very important nitrogen-containing het- furosemide used as a diuretic, amprenavir used in HIV therapy, sul- erocyclic compounds that have variety of pharmacological activity. fathiazole as an antibacterial agent, and acetazolamide as a carbonic Heterocycles containing phthalazine moiety have been reported to possess anhydrase inhibitor [12]. However, sulfonamides are also as effective different pharmacological properties, and they have been commonly lactoperoxidase inhibitors [13]. ⁎ Corresponding authors. E-mail addresses: [email protected] (C. Türkeş), [email protected] (M. Arslan). https://doi.org/10.1016/j.bioorg.2019.103004 Received 27 April 2019; Received in revised form 15 May 2019; Accepted 19 May 2019 Available online 21 May 2019 0045-2068/ © 2019 Elsevier Inc. All rights reserved. C. Türkeş, et al. Bioorganic Chemistry 89 (2019) 103004 Scheme 1. Structure of some commercially available phthalazine derivative drugs. Sulfonamide compounds inhibit carbonic anyhdrase (CA) enzymes infrared spectra of compounds 5a-l, it was possible to observe the ab- −1 in a large scale [14–16], and they have been employed for more than sorptions around 3300 cm relating to NH2 stretchings and absorp- 50 years as agents to reduce blood pressure, in the treatment of diseases tions around 1700 cm−1 from carbonyl moiety stretching. As can be such as now potentially cancer, glaucoma, heart failure, and epilepsy. seen in the literature [37], there are two peaks assigned to S]O as Some clinically used sulfonamides such as ethoxzolamide, acet- symmetric and asymmetric stretching. The peaks of asymmetric and azolamide, dichlorphenamide, and methazolamide have been employed symmetric stretch are appeared around 1300 and 1100 cm−1, respec- as systemic CA inhibitors since the 1950s. [17]. tively. Carbonic anhydrase isoenzymes (CAs) catalyze dehydration and hydration reactions of carbonic acid (H2CO3), and carbon dioxide 2.2. Biological evaluation (CO2); in the dehydration reaction H2CO3 is converted to CO2, although + the hydration reaction produces hydrogen (H ) and bicarbonate The novel N-substituted phthalazine sulfonamides obtained here − (HCO3 ) ions from CO2. [18–22]. This reaction has a crucial role in were tested as inhibitors of pharmacologically and physiologically re- some vital physiologic functions linked to metabolic pathways involved lated the cytosolic hCA I, and II by esterase assay. Also, it was in- in CO2 [23]. Because of that, their modulation is employed for a long vestigated the inhibition effects on AChE enzyme activity of these time in the treatment of several diseases such as epilepsy [24], edema compounds. Their activities were compared to the acetazolamide (AAZ) [25], glaucoma [26]. Recently, inhibitors of CAs have been employed as and tacrine (TAC) which is standard reference inhibitors for hCA and a novel approach for the treatment of the cerebral ischemia [27] dif- AChE. ferent forms of the tumor [28] and neuropathic pain [29]. (i) hCA I is expressed in normal colorectal mucosa and found at the Alzheimer’s disease (AD) is a significant problem for old people highest level in erythrocytes [38]. As for hCA I, IC50 values for novel worldwide. This disease can affect many aspects of a person’s life synthesized N-substituted phthalazine sulfonamide derivatives showed [30–32]. Also, there is no cure for AD disease, but several drugs are in the ranging from 12.42 ± 0.23 to 32.80 ± 0.49 nM and Ki con- employed for the cure [33]. Acetylcholinesterase inhibitors (AChEI) stants in the range of 6.80 ± 0.10–85.91 ± 7.57 nM. It exhibited that have been developed as an impact of the cholinergic assumption of Ki constants order of synthesized sulfonamides inhibitory strength was cognitive decline [34]. Also, the effectiveness of these treatments has 5b (Ki: 6.80 ± 0.10 nM) > 5 h (Ki: 9.26 ± 0.16 nM) > 5 k (Ki: been investigated in a large number of randomized controlled tests 9.84 ± 0.13 nM) > 5e (Ki: 10.35 ± 0.10 nM) > 5c (Ki: between cognitive, global, neuropsychiatric domains, and functional 10.59 ± 0.14 nM) > 5i (Ki: 15.10 ± 0.16 nM) > 5 g (Ki: [35]. AChEI compounds are employed for the treatment of mild-to- 16.85 ± 0.20 nM) > 5j (Ki: 20.01 ± 0.31 nM) > 5d (Ki: moderate AD. These compounds inhibit AChE, which is responsible for 20.69 ± 0.35 nM) > 5a (Ki: 49.31 ± 0.25 nM) > 5l (Ki: the separation of acetylcholine (ACh), a neurotransmitter molecule 54.23 ± 4.62 nM) > 5f (Ki: 85.91 ± 7.57 nM). It is well known that related to memory function [36]. incorporation of electron-donating groups resulted in a lessen hCA In this study, a dozen novel N-substituted phthalazine sulfonamide isoenzymes activity. Unlike this impact, addition of electron-with- compounds were synthesized, and their inhibitory effects on the ac- drawing groups in the inhibitor improved the inhibition impacts. The tivity of human carbonic anhydrase (hCA) I, II and acetylcholinesterase best inhibitor was 2-(4-sulfamoylbenzoyl)-8-flouro-2,3-dihy- (AChE) were evaluated. drophthalazine-1,4-dione (5b)(Figs. 1 and 2) when compared to AAZ (Ki: 434.55 ± 11.91 nM), which is used for positive control. Also, the least 2. Results and discussion active was 2-(4-sulfamoylbenzoyl)-6-carboxy-2,3-dihydrophthalazine-1,4- dione (5f) for hCA I. Compound 5b decreased the enzyme activity ∼ 13 2.1. Chemistry fold compared to 5f (Tables 1 and 2). hCA II is a cytosolic enzyme and highly active [39]. As shown in 4-Sulfonylamide ester was prepared from 4-Sulfamoylbenzoic acid Table 1, the inhibition profile of the novel synthesized sulfonamides was in ethanol with a catalytic amount of sulfuric acid by refluxing
Load more

Recommended publications
  • Catalytic Asymmetric Di Hydroxylation
    Chem. Rev. 1994, 94, 2483-2547 2483 Catalytic Asymmetric Dihydroxylation Hartmuth C. Kolb,t Michael S. VanNieuwenhze,* and K. Barry Sharpless* Department of Chemistry, The Scripps Research Institute, 10666 North Torfey Pines Road, La Jolla, California 92037 Received Ju/y 28, 1994 (Revised Manuscript Received September 14, 1994) Contents 3.1.4. Differentiation of the Hydroxyl Groups by 2524 Selective, Intramolecular Trapping 1. Introduction and General Principles 2483 3.1.5. Miscellaneous Transformations 2525 2. Enantioselective Preparation of Chiral 1,2-Diols 2489 3.2. Preparation of Chiral Building Blocks 2527 from Olefins 3.2.1. Electrophilic Building Blocks 2527 2.1. Preparation of Ligands, Choice of Ligand, 2489 Scope, and Limitations 3.2.2. Chiral Diol and Polyol Building Blocks 2529 2.1.1. Preparation of the Ligands 2490 3.2.3. Chiral Monohydroxy Compounds Derived 2529 from Diols 2.1 -2. Ligand Choice and Enantioselectivity Data 2490 3.2.4. 5- and 6-Membered Heterocycles 2530 2.1.3. Limitations 2491 3.3. Preparation of Chiral Auxiliaries for Other 2530 2.2. Reaction Conditions 2493 Asymmetric Transformations 2.2.1. Asymmetric Dihydroxylation of the 2493 3.3.1. Preparation of 2530 “Standard Substrates” (1 R,2S)-trans-2-phenylcyclohexanol 2.2.2. Asymmetric Dihydroxylation of 2496 3.3.2. Optically Pure Hydrobenzoin (Stilbenediol) 2531 Tetrasubstituted Olefins, Including Enol and Derivatives Ethers 4. Recent Applications: A Case Study 2536 2.2.3. Asymmetric Dihydroxylation of 2496 Electron-Deficient Olefins 5. Conclusion 2538 2.2.4. Chemoselectivity in the AD of Olefins 2497 6. References and Footnotes 2542 Containing Sulfur 2.3.
    [Show full text]
  • A Concise Review on Phthlazine Derivatives and Its Biological Activities
    Aswathy. J et al /J. Pharm. Sci. & Res. Vol. 11(7), 2019, 2526-2532 A Concise Review on Phthlazine Derivatives and its Biological Activities Aswathy. J M.Pharm, Department of Pharmaceutical Chemistry, Ezhuthachan College of Pharmaceutical Sciences, Marayamuttom Neyyattinkara, Trivandrum, India-695124 Abstract Phthalazine has good attention in the field of research study due to its wide spectrum of biological activity and therapeutic applications. Phthalazine is a good lead compound for the synthesis of novel drugs. There is a growing interest in the synthesis of several phthalazines derivatives as better drug candidates for the treatment of various diseases. Phthalazine contains a strong pharmacophoric moiety and ring structure it attracts the researchers to this nucleus for the synthesis of novel drugs. Through this review, introduce a new way for a researcher by introducing this nucleus and develop a novel class of drugs who have a better therapeutic profile. In this review, mainly discuss the different pharmacological activity of phthalazine which has already discussed by the researcher. These reports have resulted in a great number of contributions in diverse areas of interest. This study may produce a new way for the researchers to design and develop the phthalazine derivatives with good pharmacological activities. Keywords: Anticancer drug, anticonvulsant activity, antimicrobial agent, phthalazine and tuberculosis. INTRODUCTION activities of phthalazine (figure 1) and phthalazin-1(2H)- Phthalazine is a nitrogen-containing heterocyclic one (figure 2), encouraged us for the designing of new compound. Several research studies are focused on the molecules [1]. phthalazine nucleus due to their wide applicability. Phthalazine derivatives are promising drug candidate for PHARMACOLOGICAL ACTIVITIES OF PHTHALAZINE the treatment of various diseases.
    [Show full text]
  • Recent Developments in Chemistry of Phthalazines
    stry: Cu i rre em n t El-Azm et al., Organic Chem Curr Res 2015, 4:1 h R C e c s i e n a DOI: 10.4172/2161-0401.1000132 a r Organic Chemistry c g r h O ISSN: 2161-0401 Current Research ResearchReview Article Article OpenOpen Access Access Recent Developments in Chemistry of Phthalazines Fatma SM Abu El-Azm*, Mahmoud R Mahmoud, and Mohamed H Hekal Chemistry Department, Faculty of Science, Ain Shams University, Abbassia, Cairo, Egypt Abstract This review highlights the methods used for the synthesis of phthalazine derivatives and fused phthalazinones. Their reactivity and synthetic importance were investigated. Phthalazine derivatives can be used as building blocks for heterocycles as well as fused heterocyclic compounds. Keywords: Phthalazine derivatives; Pyrazolophthalazines; were tested [59]. An expeditious one-pot method has been developed Indazolophthalazines; [1,2,4] Triazolophthalazines for the synthesis of aryl, heteryl thiadiazinyl-phthalazin-1,4-diones via a multicomponent approach. Reaction of phenacyl bromides 22 with Introduction thiocarbohydrazide 23 and phthalic anhydride afforded corresponding Among a large variety of nitrogen-containing heterocyclic aryl thiadiazinyl-phthalazine-1,4-diones 24 similarly, reaction of compounds, heterocyclic containing hydrazine has received 3-(2-bromoacetyl) coumarins 25 with thiocarbohydrazide and phthalic considerable attention because of their pharmacological properties anhydride afforded required heterylthiadiazinyl-phthalazine-1,4- and clinical applications [1-6]. Phthalazine derivatives were reported diones 26 under the same reaction conditions in excellent yields [60] to possess anticonvulsant [7-10], cardiotonic [11], antitumor [12-16], (Scheme 6). antihypertensive [17-19], antithrombotic [20], a ntidiabetic [21,22], Hydrazines with 2-acyl benzoic acids: Kirill et al.
    [Show full text]
  • Download-PDF
    Journal of Pharmaceutical Research International 27(6): 1-15, 2019; Article no.JPRI.44928 ISSN: 2456-9119 (Past name: British Journal of Pharmaceutical Research, Past ISSN: 2231-2919, NLM ID: 101631759) An Overview of Different Synthetic Routes for the Synthesis of Phthalazine Derivatives Smita Singh1,2 and Nitin Kumar3* 1IFTM University, Muradabad, Uttar Pradesh, India. 2K. N. Modi Institute of Pharmaceutical Education and Research, Modinagar, Uttar Pradesh, India. 3Department of Pharmacy, Sushant School of Health Sciences, Ansal University, Gurugram, 122003, India. Authors’ contributions This work was carried out in collaboration between both authors. Both authors read and approved the final manuscript. Article Information DOI: 10.9734/JPRI/2019/v27i630189 Editor(s): (1) Dr. Carlos M. Contreras, Unidad Periferica Xalapa, Instituto de Investigaciones Biomedicas, UNAM, Mexico and Instituto de Neuroetologia, Universidad Veracruzana, Mexico. (2) Dr. Jinyong Peng, Professor, College of Pharmacy, Dalian Medical University, Dalian, China. (3) Dr. Ali Nokhodchi, Professor of Pharmaceutics and Drug Delivery, School of Life Sciences, University of Sussex, UK. Reviewers: (1) Sangeetha A/P Arullappan, Jalan Universiti, Malaysia. (2) Manojit Pal, University of Hyderabad, India. (3) B. Satish Jadhav, Balbhim College, India. Complete Peer review History: http://www.sdiarticle3.com/review-history/44928 Received 14 October 2018 Review Article Accepted 31 December 2018 Published 08 June 2019 ABSTRACT This review paper describes the different synthetic routes used for the synthesis of substituted phthalazine derivatives. Phthalazines have been used as building blocks for the synthesis of a new molecule with heterocyclic structure. These new molecules are highly useful in medicinal chemistry for the researchers leading to the further development of new molecules which have potency and effectiveness to produce a desired pharmacological response.
    [Show full text]
  • Dissociation Constants of Organic Acids and Bases
    DISSOCIATION CONSTANTS OF ORGANIC ACIDS AND BASES This table lists the dissociation (ionization) constants of over pKa + pKb = pKwater = 14.00 (at 25°C) 1070 organic acids, bases, and amphoteric compounds. All data apply to dilute aqueous solutions and are presented as values of Compounds are listed by molecular formula in Hill order. pKa, which is defined as the negative of the logarithm of the equi- librium constant K for the reaction a References HA H+ + A- 1. Perrin, D. D., Dissociation Constants of Organic Bases in Aqueous i.e., Solution, Butterworths, London, 1965; Supplement, 1972. 2. Serjeant, E. P., and Dempsey, B., Ionization Constants of Organic Acids + - Ka = [H ][A ]/[HA] in Aqueous Solution, Pergamon, Oxford, 1979. 3. Albert, A., “Ionization Constants of Heterocyclic Substances”, in where [H+], etc. represent the concentrations of the respective Katritzky, A. R., Ed., Physical Methods in Heterocyclic Chemistry, - species in mol/L. It follows that pKa = pH + log[HA] – log[A ], so Academic Press, New York, 1963. 4. Sober, H.A., Ed., CRC Handbook of Biochemistry, CRC Press, Boca that a solution with 50% dissociation has pH equal to the pKa of the acid. Raton, FL, 1968. 5. Perrin, D. D., Dempsey, B., and Serjeant, E. P., pK Prediction for Data for bases are presented as pK values for the conjugate acid, a a Organic Acids and Bases, Chapman and Hall, London, 1981. i.e., for the reaction 6. Albert, A., and Serjeant, E. P., The Determination of Ionization + + Constants, Third Edition, Chapman and Hall, London, 1984. BH H + B 7. Budavari, S., Ed., The Merck Index, Twelth Edition, Merck & Co., Whitehouse Station, NJ, 1996.
    [Show full text]
  • Synthesis of Novel Series of Phthalazine Derivatives As Potential Antitumor Agents
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by International Institute for Science, Technology and Education (IISTE): E-Journals Chemical and Process Engineering Research www.iiste.org ISSN 2224-7467 (Paper) ISSN 2225-0913 (Online) Vol.10, 2013 Synthesis of Novel Series of Phthalazine Derivatives as Potential Antitumor Agents Ashraf Farouk Wasfy *, Aly Abdelmaboud Aly, Mohamed Sayed Behalo, Nora Sobhi Mohamed Chemistry department, Faculty of science, Benha University Benha, Egypt. P.O. Box 13518 Tel.: +2.010.1599607Fax: +2.013.3222578 E-mail address: [email protected] (Nora Sobhi) e-mail: [email protected] Abstract: A novel series of phthalazine derivatives bearing isoindol-1,3-dione moiety were synthesized by treating 2-[4-(4- chlorophthalazine-1-yl)phenyl]-1H-isoindole-1,3-(2 H)-dione 3 with various chemical reagents.The newly synthesi- zed compounds were characterized on the basis of their spectral ( 1H NMR, 13 C NMR, Ms, IR) analyses. In vitro , most of the synthesized derivatives were screened for their antitumor activity against HepG2 cells using MTT assay. Compounds 11, 18 and 19c showed the most potent cytotoxic effect concluded from their IC 50 values 217.4, 240.3 and 234.5 µg/ml respectively. Key Words: Phthalazin-1-(2 H)-One; chlorophthalazine; isoindol-1,3-dione; antitumor activity. 1. Introduction: Nitrogen-containing heterocycles possesses diverse chemotherapeutic activities [1,2] . Among a large variety of nitrogen-containing heterocyclic compounds, phthalazin-1(2 H)-ones, they were reported to be used as efficient antitumors [3] and therapeutic agents [4] . N-(4-Chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1- amine, also known as Vatalanib has been shown to serve as anticancer agent (Fig.1) .
    [Show full text]
  • The Catalytic Hydrogenation of Benzodiazines
    THE CATALYTIC HYDROGENATION OF BENZODIAZINES: I. PHTHALAZINE II. QUINAZOLINE A Dissertation Presented to the Department of Chemistry Brigha~ Young University In Partial Fulfillment of the Requirements for the Degre~ Doctor of Philosophy by Danny Lee Elder August 1969 This dissertation, by Danny Lee Elder, is accepted in its present form b y the Department of Chemistry of Brigham Young University as satisfying the dissertation requirement for the degree of Doctor of Philosophy. ii . , TO Lynette, David, and Douglas iii ACKNOWLEDGEMENTS Deep appreciation is expressed to Dr. H. Smith Broadbent, without whose friendly association, patient help, and kindly ex- · tended advice this research problem could not have been carried out. Gratitude is also expressed £or the many extra-academic endeavors Dr. Broadbent has made on my behalf. Appreciation is extended to the Department of Chemistry of Brigham Young University for financial support in the form of teaching and research assistantships. My wife deserves special thanks for her encouragement, patience, understanding, and especially, for making it all worth- while. Finally, sincere thanks go to a great group of fellow-graduate students--Craig Argyle, Weldon Burnham, Vic Mylroie, Wes Parish, and Walter Sudweeks--for helpful discussions, comrade- ship, and most of all, for the memorable hours spent at such places as Anderson Lake, Four-Lakes Basin, Klondike Bluff, and of course, "Organic Pass, 11 (Grosebeck Pass). iv TABLE OF CONTENTS Chapter Page I. INTRODUCTION • • • • • • • • • • • • • • • 1 II. LITERATURE REVIEW • • • • • • • • • • • • 4 Phthalaz~ne • • • • . 4 Structure and properties • • • • • • • • • · 4 Synthesis of phthalazine • • • • • • • • • 8 Reduced phthalazines • • • • • • • • • • 10 Quinazoline • • • • • • . 12 Structure and properties • . • 12 Synthesis of quinazoline • • • • • 15 Reduced quinazolines • • • • 18 Catalytic Hydrogenation of Benzoazines and Benzodiazines • • • • • • • • 20 Quinoline .
    [Show full text]
  • Essentials of Heterocyclic Chemistry-I Heterocyclic Chemistry
    Baran, Richter Essentials of Heterocyclic Chemistry-I Heterocyclic Chemistry 5 4 Deprotonation of N–H, Deprotonation of C–H, Deprotonation of Conjugate Acid 3 4 3 4 5 4 3 5 6 6 3 3 4 6 2 2 N 4 4 3 4 3 4 3 3 5 5 2 3 5 4 N HN 5 2 N N 7 2 7 N N 5 2 5 2 7 2 2 1 1 N NH H H 8 1 8 N 6 4 N 5 1 2 6 3 4 N 1 6 3 1 8 N 2-Pyrazoline Pyrazolidine H N 9 1 1 5 N 1 Quinazoline N 7 7 H Cinnoline 1 Pyrrolidine H 2 5 2 5 4 5 4 4 Isoindole 3H-Indole 6 Pyrazole N 3 4 Pyrimidine N pK : 11.3,44 Carbazole N 1 6 6 3 N 3 5 1 a N N 3 5 H 4 7 H pKa: 19.8, 35.9 N N pKa: 1.3 pKa: 19.9 8 3 Pyrrole 1 5 7 2 7 N 2 3 4 3 4 3 4 7 Indole 2 N 6 2 6 2 N N pK : 23.0, 39.5 2 8 1 8 1 N N a 6 pKa: 21.0, 38.1 1 1 2 5 2 5 2 5 6 N N 1 4 Pteridine 4 4 7 Phthalazine 1,2,4-Triazine 1,3,5-Triazine N 1 N 1 N 1 5 3 H N H H 3 5 pK : <0 pK : <0 3 5 Indoline H a a 3-Pyrroline 2H-Pyrrole 2-Pyrroline Indolizine 4 5 4 4 pKa: 4.9 2 6 N N 4 5 6 3 N 6 N 3 5 6 3 N 5 2 N 1 3 7 2 1 4 4 3 4 3 4 3 4 3 3 N 4 4 2 6 5 5 5 Pyrazine 7 2 6 Pyridazine 2 3 5 3 5 N 2 8 N 1 2 2 1 8 N 2 5 O 2 5 pKa: 0.6 H 1 1 N10 9 7 H pKa: 2.3 O 6 6 2 6 2 6 6 S Piperazine 1 O 1 O S 1 1 Quinoxaline 1H-Indazole 7 7 1 1 O1 7 Phenazine Furan Thiophene Benzofuran Isobenzofuran 2H-Pyran 4H-Pyran Benzo[b]thiophene Effects of Substitution on Pyridine Basicity: pKa: 35.6 pKa: 33.0 pKa: 33.2 pKa: 32.4 t 4 Me Bu NH2 NHAc OMe SMe Cl Ph vinyl CN NO2 CH(OH)2 4 8 5 4 9 1 3 2-position 6.0 5.8 6.9 4.1 3.3 3.6 0.7 4.5 4.8 –0.3 –2.6 3.8 6 3 3 5 7 4 8 2 3 5 2 3-position 5.7 5.9 6.1 4.5 4.9 4.4 2.8 4.8 4.8 1.4 0.6 3.8 4 2 6 7 7 3 N2 N 1 4-position
    [Show full text]
  • A Convenient Access to Thienyl-Substituted Phthalazines 1245 M
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Universidade do Minho: RepositoriUM Nov-Dec 2005 A Convenient Access to Thienyl-substituted Phthalazines 1245 M. Manuela M. Raposo,a* Ana M. B. A. Sampaioa and G. Kirschb a Centro de Química, Universidade do Minho, Campus de Gualtar 4710-057 Braga, Portugal b Laboratoire d'Ingénierie Moléculaire et Biochimie Pharmacologique, UFR SciFA/Université de Metz, 1, Boulevard Arago, Metz Technopôle, 57078 Metz Cedex 3, France Received November 3, 2004 A synthesis of 1-alkoxy- and 1-amino- substituted 4-(2-thienyl)-phthalazines is described from halo- derivatives of 4-(2-thienyl)-1-(2H)-phthalazinone 3. J. Heterocyclic Chem., 42, 1245 (2005). Introduction. Chlorine, bromine and triflate thienyl-substituted phtha- The practical interest upon phthalazine derivatives is lazines 4 and 5 were synthesized in order to be used as pre- based on their widespread applications [1-4]. Phthalazines, cursors on the synthesis of 1-alkoxy- and 1-amino-phtha- like others members of the isomeric diazine series, have lazines 6-7. These derivatives could also be used in the found wide applications as therapeutic agents [2,5-28]. future, as coupling components in palladium catalyzed Phthalazines are also commonly used as ligands in transi- cross-coupling reactions to obtain more complex mole- tion metal catalysis, [29-34] as chemiluminescent materi- cules with potential applications in NLO [52]. For this als [35-38] and for optical applications [39]. kind of application the substitution of the phenyl ring by Despite their significance, there are only a limited num- the thiophene ring was already demonstrated to be very ber of routes for the synthesis of phthalazines.
    [Show full text]
  • IUPAC Nomenclature of Fused and Bridged Fused Ring Systems
    Pure &App/. Chern., Vol. 70, No. 1, pp. 143-216, 1998. Printed in Great Britain. Q 1998 IUPAC INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY ORGANIC CHEMISTRY DIVISION COMMISSION ON NOMENCLATURE OF ORGANIC CHEMISTRY (111.1) NOMENCLATURE OF FUSED AND BRIDGED FUSED RING SYSTEMS (IUPAC Recommendations 1998) Prepared for publication by G. P. MOSS Department of Chemistry, Queen Mary and Westfield College, Mile End Road, London, El 4NS, UK Membership of the Working Party (1982-1997): A. T. Balaban (Romania), A. J. Boulton (UK), P. M. Giles, Jr. (USA), E. W. Godly (UK), H. Gutmann (Switzerland), A. K. Ikizler (Turkey), M. V. Kisakiirek (Switzerland), S. P. Klesney (USA), N. Lozac’h (France), A. D. McNaught (UK), G. P. Moss (UK), J. Nyitrai (Hungary), W. H. Powell (USA), Ch. Schmitz (France), 0. Weissbach (Federal Republic of Germany) Membership of the Commission on Nomenclature of Organic Chemistry during the preparation of this document was as follows: Titular Members: 0. Achmatowicz (Poland) 1979-1987; J. Blackwood (USA) 1996; H. J. T. Bos (Netherlands) 1987-1995, Vice-chairman, 1991- ; J. R. Bull (Republic of South Africa) 1987-1993; F. Cozzi (Italy) 1996- ; H. A. Favre (Canada) 1989-, Chairman, 1991- ; P. M. Giles, Jr. (USA) 1989-1995; E. W. Godly (UK) 1987-1993, Secretary, 1989-1993; D. Hellwinkel (Federal Republic of Germany) 1979-1987, Vice-Chainnan, 1981-1987; B. J. Herold (Portugal) 1994- ; K. Hirayama (Japan) 1975-1983; M. V. Kisakiirek (Switzerland) 1994, Vice-chairman, 1996- ; A. D. McNaught (UK) 1979-1987; G. P. Moss (UK) 1977-1987, Chairman, 1981-1987, Vice-chairman, 1979-1981; R.
    [Show full text]
  • On the Basicity of Conjugated Nitrogen Heterocycles in Different Media
    On the basicity of conjugated nitrogen heterocycles in different media Märt Lõkov,1 Sofja Tshepelevitsh,1 Agnes Heering,1 Paul G. Plieger,2 Robert Vianello,3 Ivo Leito*,1 1 University of Tartu, Institute of Chemistry, Ravila 14a, Tartu 50411, Estonia 2 Institute of Fundamental Sciences, Massey University, Private Bag 11 222, Palmerston North, New Zealand 3 Computational Organic Chemistry and Biochemistry Group, Ruđer Bošković Institute, Bijenička cesta 54, HR–10000 Zagreb, Croatia. Abstract This work explores the relationship between the structure and solvent effects on the basicity of a large selection of conjugated N-heterocyclic nitrogen bases in different media: polar aprotic solvent acetonitrile, polar protic solvent water and the gas phase. Altogether 58 previously unpublished basicity values in different media for 39 compounds are presented, including 30 experimentally determined pKa values in acetonitrile. We present the pKa and gas phase basicity values for quino[7,8-h]quinoline, which is one of the most basic conjugated nitrogen heterocyclic compounds without basicity-enhancing substituents. The basicity trends are rationalized by comparing basicity data of related compounds in different solvents, as well as by using isodesmic reactions. The gas-phase basicity is predominantly determined by the ability of a molecule to disperse the excess positive charge over a large number of atoms. In solution the situation is less clear and smaller systems with localized charge often lead to higher basicities because of solvent effects. In particular, it was found that fusion of an additional benzene ring does not always lead to basicity increase in solution: its effect can be either basicity-increasing or decreasing, depending on the ring size, number and position of nitrogen atoms and medium.
    [Show full text]
  • Structural Identification Between Phthalazine-1,4-Diones and N-Aminophthalimides Via Vilsmeier Reaction
    molecules Article Structural Identification between Phthalazine-1,4-Diones and N-Aminophthalimides via Vilsmeier Reaction: Nitrogen Cyclization and Tautomerization Study Cheng-Yen Chung 1,2, Ching-Chun Tseng 1,2, Sin-Min Li 3, Shuo-En Tsai 1,2, Hui-Yi Lin 1,* and Fung Fuh Wong 1,* 1 School of Pharmacy, China Medical University, No. 91, Hsueh-Shih Rd., Taichung 40402, Taiwan; [email protected] (C.-Y.C.); [email protected] (C.-C.T.); [email protected] (S.-E.T.) 2 The Ph.D. Program for Biotech Pharmaceutical Industry and School of Pharmacy, China Medical University, No. 91, Hsueh-Shih Rd., Taichung 40402, Taiwan 3 Institute of New Drug Development, China Medical University, No. 91 Hsueh-Shih Rd., Taichung 40402, Taiwan; [email protected] * Correspondence: [email protected] (H.-Y.L.); [email protected] or [email protected] (F.F.W.); Tel.: +886-422-053-366 (ext. 5112) (H.-Y.L.); +886-422-053-366 (ext. 5603) (F.F.W.); Fax: +886-422-078-083 (H.-Y.L. & F.F.W.) Abstract: N-Aminophthalimides and phthalazine 1,4-diones were synthesized from isobenzofuran- 1,3-dione, isoindoline-1,3-dione, furo [3,4-b] pyrazine-5,7-dione, or 1H-pyrrolo [3,4-c] pyridine-1,3- dione with monohydrate hydrazine to carry out the 5-exo or 6-endo nitrogen cyclization under the different reaction conditions. Based on the control experimental results, 6-endo thermodynamic hydrohydrazination and kinetical 5-exo cyclization reactions were individually selective formation. Subsequently, Vilsmeier amidination derivatization was successfully developed to probe the struc- Citation: Chung, C.-Y.; Tseng, C.-C.; tural divergence between N-aminophthalimide 2 and phthalazine 1,4-dione 3.
    [Show full text]